These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 19222903

  • 1. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
    Yadav VR, Suresh S, Devi K, Yadav S.
    J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
    [Abstract] [Full Text] [Related]

  • 2. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model.
    Yadav VR, Suresh S, Devi K, Yadav S.
    AAPS PharmSciTech; 2009 Mar; 10(3):752-62. PubMed ID: 19495987
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
    Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM.
    Food Chem Toxicol; 2009 Jun; 47(6):1311-7. PubMed ID: 19285535
    [Abstract] [Full Text] [Related]

  • 4. Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis.
    Lubbad AS, Oriowo MA, Khan I.
    Scand J Gastroenterol; 2009 Jun; 44(2):187-94. PubMed ID: 18830899
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease.
    Tyagi A, Kumar U, Reddy S, Santosh VS, Mohammed SB, Ehtesham NZ, Ibrahim A.
    Br J Nutr; 2012 Nov 14; 108(9):1612-22. PubMed ID: 22243775
    [Abstract] [Full Text] [Related]

  • 6. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C, Nácher A, Merino V, Merino-Sanjuan M, Carda C, Ruiz A, Manconi M, Loy G, Fadda AM, Diez-Sales O.
    Int J Pharm; 2011 Sep 15; 416(1):145-54. PubMed ID: 21723929
    [Abstract] [Full Text] [Related]

  • 7. Suppressive effects of a new anti-inflammatory agent, IS-741, on dextran sulfate sodium-induced experimental colitis in rats.
    Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Araki Y, Fujiyama Y, Bamba T.
    Int J Mol Med; 2002 Apr 15; 9(4):391-6. PubMed ID: 11891534
    [Abstract] [Full Text] [Related]

  • 8. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
    Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM.
    J Pharmacol Exp Ther; 2001 Nov 15; 299(2):775-81. PubMed ID: 11602694
    [Abstract] [Full Text] [Related]

  • 9. Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis.
    Cho EY, Choi SC, Lee SH, Ahn JY, Im LR, Kim JH, Xin M, Kwon SU, Kim DK, Lee YM.
    Int Immunopharmacol; 2011 Apr 15; 11(4):412-7. PubMed ID: 21187179
    [Abstract] [Full Text] [Related]

  • 10. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H, Okazaki K, Tabata Y, Chiba T.
    J Gastroenterol; 2003 Mar 15; 38 Suppl 15():59-62. PubMed ID: 12698874
    [Abstract] [Full Text] [Related]

  • 11. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D.
    Gastroenterology; 2010 Mar 15; 138(3):843-53.e1-2. PubMed ID: 19909746
    [Abstract] [Full Text] [Related]

  • 12. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A.
    J Control Release; 2007 Nov 20; 123(3):211-8. PubMed ID: 17889397
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.
    Hayashi Y, Aoyagi K, Morita I, Yamamoto C, Sakisaka S.
    Scand J Gastroenterol; 2009 Nov 20; 44(11):1323-31. PubMed ID: 19891583
    [Abstract] [Full Text] [Related]

  • 14. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
    Jaspart S, Piel G, Delattre L, Evrard B.
    Expert Opin Drug Deliv; 2005 Jan 20; 2(1):75-87. PubMed ID: 16296736
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R, Dubey R, Omrey P, Vyas SP, Jain SK.
    J Drug Target; 2010 Sep 20; 18(8):589-601. PubMed ID: 20088681
    [Abstract] [Full Text] [Related]

  • 16. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M, Belgamwar V, Gattani S, Surana S, Tekade A.
    Drug Deliv; 2010 Jan 20; 17(1):38-47. PubMed ID: 22747074
    [Abstract] [Full Text] [Related]

  • 17. Solid lipid microparticles as a sustained release system for pulmonary drug delivery.
    Jaspart S, Bertholet P, Piel G, Dogné JM, Delattre L, Evrard B.
    Eur J Pharm Biopharm; 2007 Jan 20; 65(1):47-56. PubMed ID: 16962749
    [Abstract] [Full Text] [Related]

  • 18. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F, Zhang MC, Zhu Y.
    Ophthalmologica; 2008 Sep 14; 222(3):178-86. PubMed ID: 18497527
    [Abstract] [Full Text] [Related]

  • 20. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
    Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):223-30. PubMed ID: 19491009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.